The New Face of Traditional Chinese Medicine

  title={The New Face of Traditional Chinese Medicine},
  author={D. Normile},
  pages={188 - 190}
  • D. Normile
  • Published 2003
  • Medicine
  • Science
  • TOKYO-- This year, the U.S. Food and Drug Administration approved a phase II trial to test the efficacy of Kanglaite in treating non-small-cell lung cancer, making Kanglaite the first drug derived from a traditional Chinese herbal remedy to go into clinical trials in the United States. Asian governments are hoping that high-volume screening and rigorous clinical trials will unlock the secrets of ancient herbal remedies--and that the results will pass muster with Western scientists. 
    481 Citations

    Topics from this paper.

    Clinical Immunology and Traditional Herbal Medicines
    • S. Plaeger
    • Medicine
    • Clinical Diagnostic Laboratory Immunology
    • 2003
    • 42
    • PDF
    Ayurveda and Traditional Chinese Medicine: A Comparative Overview
    • 557
    • PDF
    Chinese herbal medicine in the treatment of chronic kidney disease.
    • 56
    Traditional Chinese Medicine Active Ingredient-Metal Based Anticancer Agents
    • 2
    • PDF
    Herbal Medicine Research in Taiwan*
    • 40
    • PDF